Part 6 of CEPA provides a framework to regulate the assessment and management of new living organisms, including genetically modified organisms. As you know, on October 13 of this year, Environment and Climate Change Canada and Health Canada launched consultations to help determine how the new substance notification regulations for organisms can better protect human health and the environment through increased openness and transparency in both risk assessment and the regulatory decision-making process.
In the face of what is clearly a rapidly evolving biotechnology sector, I think that the public engagement process will really help to modernize the regulations and encourage innovation in the biotech sector while we ensure that human health and the environment are protected from harmful substances. That's the balance that we try to strike in section 6 and in the overall CEPA amendments that we're proposing.